Judge Delays Plavix Trial Once More
The hearing is now set for May 27, the U.S. District Court for the Southern District of New York decided.
The U.S. court had previously agreed to delay the hearing in late March, setting it for May 13.
Co-marketed with Bristol-Myers Squibb, Plavix is Sanofi-Aventis's blockbuster stroke medication.
Since 2002, the two generic makers have been challenging Sanofi over...
To view the full article, register now.